The landscape of dementia diagnosis has progressed radically with the advent of complex biomarkers, which includes amyloid PET scans, tau imaging, and blood-dependent tests that will detect Alzheimer's pathology yrs before indicators arise. Though these technological developments depict extraordinary progress in knowing neurodegenerative conditions